Hematology

Research Faculty

Division HeadHide

Russell E. Ware, MD, PhD Director, Division of Hematology

Russell E. Ware, MD, PhD, is a recognized expert in sickle cell disease. He is the national PI for several NHLBI-funded sickle cell clinical trials and has recently begun an international program to improve the diagnosis, treatment, and research for sickle cell disease in developing countries. His laboratory focuses on genetic modifiers of sickle cell disease, as well as the pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea therapy.
Visit the Ware Research Lab.

513-517-2344 russell.ware@cchmc.org

FacultyShow

Adrienne M. Hammill, MD, PhD Research Director, Hemangioma & Vascular Malformation Program

Adrienne M. Hammill, MD, PhD, conducts clinical research on hemangiomas and vascular malformations, focusing on development of new therapies for these conditions and new tools for assessing response to therapy, including novel imaging modalities.

513-517-2234 adrienne.hammill@cchmc.org

Theodosia A. Kalfa, MD, PhD Co-Director, Erythrocyte Diagnostic Laboratory

Theodosia A. Kalfa, MD, PhD, focuses on the study of intracellular signals in erythropoiesis and mature red blood cells, specifically the signals conducted by Rho GTPases regulating terminal erythroid maturation and enucleation. Her lab also studies the role of Rac GTPases in generation of reactive oxygen species (ROS) within red blood cells from patients and animal models with sickle-cell disease along with the signaling mechanisms and consequences of increased ROS in sickle cells.
Visit the Kalfa Research Lab.

513-636-0989 theodosia.kalfa@cchmc.org

Lori Luchtman-Jones, MD Medical Director, Hemostasis & Thrombosis Laboratory

Lori Luchtman-Jones, MD, is interested in thrombosis/hemostasis as it is impacted by diseases such as sickle cell anemia. She has 19 years of experience in clinical investigation in Phase I, II, and III clinical trials. She have served as principal investigator (PI) or institutional principal investigator/clinical investigator on 14 investigator-initiated or multi-institutional NIH- and 15 industry-funded projects.

513-517-2234 lori.luchtman-jones@cchmc.org

Punam Malik, MD Director, Cincinnati Comprehensive Sickle Cell Center

Punam Malik, MD, works to correct the gene responsible for sickle cell anemia. One of the lab’s major projects uses gene therapy to treat sickle cell disease. The lab is also interested in gene therapy for other diseases. She has developed various methods for delivering corrective genes to cells, improving methods for gene therapy in general.

513-636-1333 punam.malik@cchmc.org

Patrick T. McGann, MD, MS Member, Division of Hematology

Patrick T. McGann, MD, MS, focuses his research efforts on improving the diagnosis, care, and outcomes for children with sickle cell anemia across the world, particularly in sub-Saharan Africa. Current projects include the investigation of hydroxyurea in Africa (REACH), the development and testing of inexpensive point-of-care diagnostics in hematology, and analysis of serotype distribution of invasive pneumococcal disease in Angola.

513-517-2234 patrick.mcgann@cchmc.org

Eric Mullins, MD Research Director, Hemophilia Treatment Center

Eric Mullins, MD, has a research interest in the interplay between the hemostatic system and the immune system in the setting of inflammatory diseases and infection.

513-517-2234 eric.mullins@cchmc.org

Omar Niss, MD Member, Division of Hematology

Omar Niss, MD, focuses on studying the cardiopulmonary complications of sickle cell disease including the characterization of the sickle cardiomyopathy, renal complications of sickle cell disease, and congenital anemias.

513-517-2234 omar.niss@cchmc.org

Joseph S. Palumbo, MD Director, Comprehensive Thrombophilia Center

Joseph S. Palumbo, MD, focuses on interactions between the hemostatic system and innate immunity effecting tumor progression and Langerhans' cell histiocytosis.

513-517-2234 joe.palumbo@cchmc.org

Charles T. Quinn, MD, MS Medical Director, Erythrocyte Diagnostic Laboratory

Charles T. Quinn, MD, MS, focuses on characterization and treatment of cardiomyopathy and nephropathy in sickle cell disease; measurement of red blood cell turnover in sickle cell disease; pathophysiology, treatment and prevention of brain injury (structural and cognitive) in sickle cell disease; MRI methods of body iron quantitation; and new agents for immune thrombocytopenia (ITP).

513-517-2234 charles.quinn@cchmc.org

Kiersten W. Ricci, MD Clinical Director, Hemangioma & Vascular Malformation Program

513-517-2234 kiersten.ricci@cchmc.org

Lisa M. Shook, MA, MCHES, CCP Administrative Director, Comprehensive Sickle Cell Center

Lisa M. Shook, MA, MCHES, CCP, is a field service instructor in the Cincinnati Comprehensive Sickle Cell Center within the UC Department of Pediatrics. Her interests include sickle cell disease and sickle cell trait, newborn screening, health education, health literacy, chronic disease self-management and quality improvement.

513-636-7541 lisa.shook@cchmc.org

Cristina Tarango, MD Medical Director, Hemophilia Treatment Center

Cristina Tarango, MD, focuses on pediatric thrombosis and hemostasis. She also has an interest in medical education.

513-517-2234 cristina.tarango@cchmc.org

Hematology

Research Faculty

Connect With Us